Dentato-rubral and pallido-luysian
atrophy (DRPLA) is one of the family of
neurodegenerative diseases caused by expansion of a
polyglutamine tract. The drpla gene product,
atrophin-1, is widely expressed, has no known function or activity, and is found in both the nuclear and cytoplasmic compartments of neurons. Truncated fragments of
atrophin-1 accumulate in neuronal nuclei in a transgenic mouse model of DRPLA, and may underlie the disease phenotype. Using the yeast two-hybrid system, we identified ETO/MTG8, a component of
nuclear receptor corepressor complexes, as an atrophin-1-interacting
protein. When cotransfected into Neuro-2a cells,
atrophin-1 and ETO/MTG8 colocalize in discrete nuclear structures that contain endogenous mSin3A and
histone deacetylases. These structures are
sodium dodecyl sulfate-soluble and associated with the nuclear matrix. Cotransfection of ETO/MTG8 with
atrophin-1 recruits
atrophin-1 to the nuclear matrix, while
atrophin-1 and ETO/MTG8 cofractionate in nuclear matrix preparations from brains of DRPLA transgenic mice. Furthermore, in a cell transfection-based assay,
atrophin-1 represses transcription. Together, these results suggest that
atrophin-1 associates with
nuclear receptor corepressor complexes and is involved in transcriptional regulation. Emerging links between disease-associated
polyglutamine proteins, nuclear receptors, translocation-
leukemia proteins, and the nuclear matrix may have important repercussions for the pathobiology of this family of
neurodegenerative disorders.